DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that members of its senior management team will present at the following investor conferences in September:
| Stifel Nicolaus Healthcare Conference |
| Thursday, September 6 at 10:55 am ET |
| Boston, MA |
| BioCentury and Thomson Reuters' NewsMakers in the Biotech Industry |
| Friday, September 7 at 10:00 am ET |
| New York, NY |
| Rodman & Renshaw Global Investment Conference |
| Monday, September 10 at 11:40 am ET |
| New York, NY |
Webcast information and presentation materials will be available in the Investor Events section of the Company's website, www.astx.com. Both will be archived for 30 days.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273